Literature DB >> 11454040

Oncocytic papillary carcinoma with lymphoid stroma (Warthin-like tumour) of the thyroid: a distinct entity with favourable prognosis.

M Ludvíková1, A Ryska, M Korabecná, M Rydlová, M Michal.   

Abstract

AIMS: We report the clinicopathological and immunohistochemical characteristics of 12 cases of a recently recognized entity, oncocytic papillary thyroid carcinoma (PC) with lymphoid stroma (Warthin-like tumour). METHODS AND
RESULTS: The cases were retrieved from the surgical pathology files of our departments. There were 11 female patients and one male patient; they ranged in age from 45 to 85 years (mean 64.2 years). The immunohistochemical profile demonstrated positivity of tumour cells for cytokeratins, thyroglobulin, Leu-M1 and anti-mitochondrial antigen. S100 protein-positive stromal dendritic/Langerhans cells were uniformly present. Polymerase chain reaction, in situ hybridization, and immunohistochemistry for Epstein-Barr virus (EBV) detection revealed no significant positive signal. MIB-1 labelling index was low, compatible with that of 'classical' PC.
CONCLUSIONS: Warthin-like tumour is a rare variant of PC, occurring predominantly in elderly women. Its histological features are distinct and well recognizable, differentiating this tumour from a more aggressive tall-cell variant of PC. The apparent indolent behaviour seems to be consistent with the presence of dendritic/Langerhans cells and with low proliferative activity. A possible role of EBV in pathogenesis of this lesion was not proven. Further studies are necessary to determine the prognosis and metastatic potential of this neoplasm.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11454040     DOI: 10.1046/j.1365-2559.2001.01154.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  9 in total

Review 1.  Papillary carcinoma of thyroid: A 30-yr clinicopathological review of the histological variants.

Authors:  Alfred King-Yin Lam; Chung-Yau Lo; Karen Siu-Ling Lam
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

2.  Aberrant Intrathyroid Tissue: a Report of Intrathyroid Lymph Node Metastasis and a Review of Literature.

Authors:  Michael S Shawky; Win Meyer-Rochow
Journal:  Indian J Surg       Date:  2017-01-20       Impact factor: 0.656

3.  Warthin tumor-like variant of papillary thyroid carcinoma: a case with dedifferentiation (anaplastic changes) and aggressive biological behavior.

Authors:  King Yin Lam; Chung Yau Lo; William I Wei
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

4.  Occult oncocytic papillary thyroid carcinoma with lymphoid stroma (Warthin-like tumor): report of a case with concomitant mutations of BRAF V600E and V600K.

Authors:  Fei Han; Long Zhang; Suxia Zhang; Hong Zhou; Xianghua Yi
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

5.  Warthin tumor-like papillary thyroid carcinoma with a minor dedifferentiated component: report of a case with clinicopathologic considerations.

Authors:  Paolo Amico; Salvatore Lanzafame; Giovanni Li Destri; Paolo Greco; Rosario Caltabiano; Giada Maria Vecchio; Gaetano Magro
Journal:  Case Rep Med       Date:  2010-06-07

6.  Prognostic factors of papillary and follicular carcinomas in Japan based on data of kuma hospital.

Authors:  Yasuhiro Ito; Akira Miyauchi
Journal:  J Thyroid Res       Date:  2011-09-29

7.  Preoperative Cytologic Diagnosis of Warthin-like Variant of Papillary Thyroid Carcinoma.

Authors:  Jisup Kim; Beom Jin Lim; Soon Won Hong; Ju Yeon Pyo
Journal:  J Pathol Transl Med       Date:  2018-02-12

8.  Warthin-like papillary carcinoma of the thyroid gland: case report and review of the literature.

Authors:  Panagiotis Paliogiannis; Federico Attene; Federica Trogu; Mario Trignano
Journal:  Case Rep Oncol Med       Date:  2012-12-02

9.  Herpes and polyoma family viruses in thyroid cancer.

Authors:  Dimitris P Stamatiou; Stavros P Derdas; Odysseas L Zoras; Demetrios A Spandidos
Journal:  Oncol Lett       Date:  2016-01-26       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.